🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Drug-Related Side Effects and Adverse Reactions

IPGx PILOT Whole Genome Sequencing Extension Cohort NCT06766071n/a1 site📍 Bryan Texas A&M University Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site📍 Indianapolis Indiana University · Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Multi-Agent Collaborative ADR Prediction With Human-Machine Decision Comparison NCT07808866n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital · Tests: Retrospective medical record data analysis only, no clinical intervention Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites📍 Paris📍 Paris📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: Anti-Cancer Agents Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity NCT06214195Phase 31 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH) NCT07015112NA1 site📍 Barcelona Parc Sanitari Pere Virgili · Tests: Patient-centered multidisciplinary treatment review The STOP-MED CTRCD Trial NCT06183437Phase 414 sites📍 Los Angeles📍 Boston📍 Melbourne Dinesh Thavendiranathan · Tests: Stopping Heart Failure Medication(s) A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors NCT06716619Phase 11 site📍 Guangzhou Guangzhou FineImmune Biotechnology Co., LTD. · Tests: Tumor Associated Lymph node T cell, Serplulimab Injection Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites📍 New Delhi📍 Puducherry University of Geneva, Switzerland The Geriatric Emergency Department Pharmacologic Harm Prevention Project NCT07216846NA1 site📍 Delray Beach Florida Atlantic University · Tests: DNA care pathway Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing NCT06406114Phase 26 sites📍 Scottsdale📍 San Francisco📍 Boston Massachusetts General Hospital · Tests: Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, a… Reduction of Polypharmacy in Elderly People With Multiple Diseases NCT05526963NA1 site📍 Halle Martin-Luther-Universität Halle-Wittenberg · Tests: Medication plan review, Adherence support ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies NCT07191730n/a1 site📍 Caen University Hospital, Caen Interprofessional Pharmacogenomics (IPGx) Registry and Repository NCT06726590n/a1 site📍 Bryan Texas A&M University Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department NCT06692504n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System NCT04249375n/a2 sites📍 Vancouver📍 Ottawa University of British Columbia Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study NCT05851053n/a1 site📍 Groningen University Medical Center Groningen · Tests: Echocardiography IMMUNO-FIT Observational Study NCT07354971n/a1 site📍 Southampton University Hospital Southampton NHS Foundation Trust · Tests: Observational Study - No Study Intervention Clinical Determinants and Adverse Reactions to Tropicamide/Phenylephrine in Hospitalized Patients. NCT07178600n/a1 site📍 Mexico City Instituto de Oftalmología Fundación Conde de Valenciana · Tests: Ophthalmic administration of tropicamide/phenylephrine 8 mg/50 mg/mL. Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities NCT06997198Phase 41 site📍 Cleveland University Hospitals Cleveland Medical Center · Tests: Deutetrabenazine Oral Capsule A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects NCT07319364Phase 11 site📍 Zhejiang Second Affiliated Hospital, Zhejiang University, School of … · Tests: Fecal microbiota transplantation (FMT) Pharmacogenetics of Antidepressant-Induced Disinhibition NCT03953014n/a1 site📍 Calgary University of Calgary High Dimensional Analysis of Immune Cells in Pediatric Patients NCT05820802n/a1 site📍 Seoul Seoul National University Hospital Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository NCT06789601Phase 1, Phase 22 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Informatics system for eligibility monitoring, Standard eligibility monitoring Sex, Psychopharmacology, and Diabetes NCT05951660NA1 site📍 Slagelse Zealand University Hospital · Tests: Educational intervention Drug Reactions Sampling (COLLECTIONTOXIDERMIES) NCT03659227n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies NCT06664528n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ECHOCARDIOGRAPHY, ELECTROCARDIOGRAPHY (ECG), LABORATORY TESTS NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity NCT06340516NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Plasma NT-proBNP
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy